WORLD BIO SUMMIT 2023

PROGRAM

SIDE EVENTS

Program on November 21

09:00 ~

10:45 

SIDE EVENT SESSION 1.

 Korea & CEPI R&D Workshop

(Invitation only)

Grand Ballroom3F


13:00 ~

15:00

SIDE EVENT SESSION 2.

Korea & ADB 

SIDE SESSION : 

Path and Innovation Towards Climate Resilience and Low-Carbon Bio Sector

Grand Ballroom3F


[SIDE EVENT SESSION 1]
Korea & CEPI R&D Workshop(Invitation only)
 21(Tue) November
9:00~10:45
 Grand Ballroom,3F

After the COVID-19 pandemic, the need for strengthening R&D capabilities and international cooperation to prepare for the next pandemic has emerged. In this session, as the 2nd annual workshop between CEPI and Korea, participants will have a chance not only to familiarize themselves with CEPI’s Disease X Vaccine Library but also to understand the current status of public vaccine development research in Korea. Also, speakers from Korean companies developing various vaccine platforms will share global leading vaccine development research to facilitate collaborative R&D efforts on vaccine development between CEPI and Korean researchers. Please note that this session is by invitation only as confidential information may be exchanged among participants.

09:00~09:10
Opening Remaks

Soon-do Cha

President,

Korea Health Industry Development Institute (KHIDI)

Jane Halton

Chair of the Board,

Coalition for Epidemic Preparedness Innovations (CEPI)

09:10~09:15
Group Photo
09:15~09:30
CEPI’s Disease X Vaccine Library

In-Kyu Yoon 

Director and Global Head 

of Programmes and Innovative Technology,

Coalition for Epidemic Preparedness Innovations(CEPI)

09:30~09:40
Current Status and Future 
Plans for Vaccines Being 
Developed at Korean VRC

Kim Dokeun 

Director, Division of Infectious Disease Vaccine Research, 

Korea Disease Control and Prevention Agency (KDCA) 

09:40~09:50
SKBS's mRNA Platform and Beyond

Jinan Shin

Vice President, SK bioscience

09:50~10:00
Expedite-100 Project with Leveraging Novel SmartCap and STLNP Platform Technology mRNA Vaccine Development

Joo-Sung James Yang

Senior Vice President, ST Pharm

10:00~10:10
Virus-like Protein Nanoparticle (VLPNP) Platform Addressing 
Improved Development and 
Manufacturing Speed of 
Innovative Vaccine(s)

Deog-Young Choi

CEO, InThera

10:10~10:20
New Platform for Inactivated 
Vaccines Based on 
Green Technologies

Moon Se Ra

CEO, InThera

10:20~10:30
Microneedle Array Patch: 
A Novel Vaccination Technology

Jeong Yeon Kang

Research Director, Quadmedicine 

10:30~10:40
Discussion / Q&A
[Moderator] 

Baik-Lin Seong 

Director General,

Vaccine Innovative Technology ALliance Korea 


[Panels] 

In-Kyu Yoon 

Director and Global Head 

of Programmes and Innovative Technology,

Coalition for Epidemic Preparedness Innovations(CEPI)


Kim Dokeun 

Director, Division of Infectious Disease Vaccine Research, 

Korea Disease Control and Prevention Agency (KDCA) 


Jinan Shin

Vice President, SK bioscience


Joo-Sung James Yang

Senior Vice President, ST Pharm


Deog-Young Choi

CEO, InThera


Moon Se Ra

CEO, GreenVax, Inc. 


Jeong Yeon Kang

Research Director, Quadmedicine 

10:40~10:45
Closing Remarks 

Baik-Lin Seong

Director General,

Vaccine Innovative Technology ALliance Korea

[SIDE EVENT SESSION 2]
Korea &ADB SIDE SESSION :
Path and Innovation Towards Climate Resilience and Low-Carbon Bio Sector
  21(Tue) November
13:00 ~ 15:00
Grand Ballroom, 3F

Climate change has been identified as the single biggest health threat facing humanity by the World Health Organization. The health sector urgently needs to reduce its contribution to climate change, which is more than 5% of net global emissions. Climate change impacts human and animal health through extreme weather such as heatwaves, floods, and drought, through the expanding spread of infectious diseases and an added burden of non-communicable diseases, as well as through fundamental changes to the air and water supplies, and food systems. 


Addressing the environmental determinants of health should be an essential component of a One Health approach that sees human health as deeply interlinked with the health of animals, plants, the environment, and natural ecosystems. People’s physical, mental, and social health can benefit from addressing these environmental determinants of health, including those affected by climate change.


Consequently, reducing climate emissions in all sectors is needed to protect human health, animal health, and the environment from the climate crisis. It will simultaneously bring significant health gains (co-benefits) from reduced air pollution, healthy and more sustainable diets, sustainable and active transport, and more. 


Across the world, health systems in urban and rural settings face escalating challenges in responding to the myriad, growing health impacts of climate change. We must prepare for and build resilience to the impacts of extreme weather on health infrastructure, health systems themselves, and the communities they serve.

13:00~13:05
Opening Remarks 

Sungsup Ra

Deputy Director General and Deputy Group Chief, 

Sectors Group, Asian Development Bank(ADB)

13:05~13:15
Climate Mitigation in The Bio Health Area: Decarbonizing Vaccine, 
Pharmaceutical, and Diagnostics
Manufacturing Supply Chain

Patrick Osewe 

Director-Health, 

Human and Social Development Sector Office, 

Asian Development Bank(ADB)

13:15~13:25
Animal Health and Carbon Emissions

Sanjeev Kumar Balyan 

Minister, Animal Husbandry and Dairying, 

Government of India

13:25~13:35
 Investment Framework for 
Climate and Health Action

Tamer Rabie 

Lead Health Specialist in the World Bank's Health,

Nutrition and Population Global Practice

13:35~13:45
Climate Change Adaptation 
Strategies for Climate Resilient 
Health system in Asia and 
Pacific Region

Jemilah binti Mahmood

Sunway Centre for Planetary Health,

Sunway University Malaysia

13:45~13:55
Sustainable and Decarbonized 
Vaccine, Pharmaceutical, and 
Diagnostic Manufacturing - What are 
the Potential Options for Regulation?

John Skerritt 

Enterprise Professor in Health Research Impact,

University of Melbourne

13:55~14:15
Case Presentations on 
Decarbonizing Vaccine, 
Pharmaceutical, and Diagnostics Manufacturing supply Chain

Sudeep Kumar

Senior Vice President, Biological E, India


Syed S Ahmed

CEO, Techno Invention

14:15~14:55
One Health and Climate Resilient, Building Sustainable
Low Carbon Health Care
[Moderator] 

Brian Riley 

Principal Health Specialist, Human and Social Development Sector Office, Asian Development Bank(ADB)



[Panels] 

Abhijit Mitra 

Animal Husbandry Commissioner, Government of India 


Ehsanul Kabir 

Managing Director & Chief Executive Officer,

Essential Drugs Company Limited (EDCL) 


Meelan Thondoo 

Technical Officer on Climate Change and Health, 

World Health Organization(WHO) 

Asia-Pacific Centre for Environment 

and Health in the Western Pacific Region


[Panels] 

Jae Kyoun Kim

Health Specialist, 

Human and Social Development Sector Office, 

Asian Development Bank(ADB)

14:55~15:00
Closing Remarks 

Patrick Osewe 

Director-Health, 

Human and Social Development Sector Office, 

Asian Development Bank(ADB)

SIDE EVENTS

Program on November 20-21

Global Business Lounge

20(Mon) 12:00~18:00

21(Tue)  09:00~18:00

Studio 8~10

Overview 

Create a business lounge for networking among Summit attendees, including governments and international organizations, and domestic and international pharma and biotech companies.


Attendees 

Global: Representatives from international organizations, institutions, and companies such as ADB, FIND, CEPI, etc. 

Domestic : Representatives from domestic vaccine and pharma-bio companies, etc.

Business Partnering 

20(Mon) 15:30~18:00

21(Tue)  09:00~16:50

 Studio 4 Front Booth

Overview 

Operate business partnerships through preliminary demand surveys between major figures such as foreign governments, international organizations, and global pharmaceutical companies and domestic companies. 

* Reflecting demand from international organizations and foundations such as Global Seed, FIND, and Litfund for interviews with domestic companies 


Attendance 

Global: Representatives from international organizations, institutions, and companies such as ADB, FIND, CEPI, etc. 

Domestic companies: Representatives of domestic vaccine and pharmaceutical bio companies, etc.

KHIDI-FIND-RIGHT Foundation Business Networking Luncheon for Korean IVD companies 

 21(Tue) November

11:10~12:40

 Studio 8~10

Overview 

Providing global information and networking to domestic diagnostic device companies by holding a briefing session on the RIGHT Foundation and FIND R&D projects that are in high demand by companies.

11:10~11:12
Opening Remarks 

Patrick Osewe 

Director-Health, 

Human and Social Development Sector Office, 

Asian Development Bank(ADB)

11:10~11:12
Announcing the 
RIGHT Foundation-FIND  
Agreement Announcement 
of R&D Support Direction and Tasks

RIGHT Foundation 

FIND 

12:00 ~
 Networking

SIDE EVENTS Program on November 21


09:00~10:45

SIDE EVENT SESSION 1.
Korea & CEPI R&D Workshop (Invitation only)
Grand Ballroom, 3F

13:00~15:00

SIDE EVENT SESSION 2. 

Korea &ADB Side Session :
Path and Innovation Towards Climate Resilience and
Low-Carbon Bio Sector

Grand Ballroom, 3F
[SIDE EVENT SESSION 1]
Korea & CEPI R&D Workshop (Invitation only) 
Tuesday, November 21, 09:00 – 10:45   I  Grand Ballroom, 3F


After the COVID-19 pandemic, the need for strengthening R&D capabilities and international cooperation to prepare for the next pandemic has emerged.

In this session, as the 2nd annual workshop between CEPI and Korea, participants will have a chance not only to familiarize themselves with CEPI’s Disease X Vaccine Library but also to understand the current status of public vaccine development research in Korea. Also, speakers from Korean companies developing various vaccine platforms will share   global leading vaccine development research to facilitate collaborative R&D efforts on vaccine development between CEPI and Korean researchers.


Please note that this session is by invitation only as confidential information may be exchanged among participants.


Time
Program
Speaker
09:00~09:10
Opening Remarks

Soon-do Cha

President, 

Korea Health Industry Development Institute (KHIDI)


Jane Halton

 Chair of the Board, 

Coalition for Epidemic Preparedness Innovations (CEPI)

09:10∼09:15
Group Photo
09:15∼09:30
CEPI’s Disease X Vaccine Library

In-Kyu Yoon

Director and Global Head 

of Programmes and Innovative Technology, 

Coalition for Epidemic Preparedness Innovations(CEPI)

09:30∼09:40
Current Status and Future Plans 
for Vaccines Being Developed at Korean VRC

Kim Dokeun

Director, Division of Infectious Disease Vaccine Research, Korea Disease Control and Prevention Agency (KDCA) 

09:40∼09:50
SKBS's mRNA Platform and Beyond

Jinan Shin

Vice President, SK bioscience

09:50∼10:00
Expedite-100 Project with Leveraging Novel SmartCap and STLNP Platform Technology mRNA Vaccine Development

Joo-Sung James Yang

 Senior Vice President, ST Pharm

10:00~10:10
Virus-like Protein Nanoparticle (VLPNP) Platform Addressing Improved Development and Manufacturing Speed of Innovative Vaccine(s)

Deog-Young Choi

CEO, InThera

10:10∼10:20
New Platform for Inactivated Vaccines Based on Green Technologies

Moon Se Ra

CEO, GreenVax

10:20~10:30
Microneedle Array Patch: 
A Novel Vaccination Technology

Jeong Yeon Kang

Research Director, Quadmedicine

10:30~10:40
Discussion / Q&A

[Moderator] 

Baik-Lin Seong

Director General, 

Vaccine Innovative Technology ALliance Korea


[Panels]

In-Kyu Yoon

Director and Global Head of 

Programmes and Innovative Technology, 

Coalition for Epidemic Preparedness Innovations(CEPI)


Kim Dokeun

Director, Division of Infectious Disease Vaccine Research, Korea Disease Control and Prevention Agency (KDCA) 


Jinan Shin

Vice President, SK bioscience


Joo-Sung James Yang

 Senior Vice President, ST Pharm


Deog-Young Choi

CEO, InThera


Moon Se Ra

CEO, GreenVax


Jeong Yeon Kang

Research Director, Quadmedicine

10:40~10:45
Closing Remarks

Baik-Lin Seong

Director General, 

Vaccine Innovative Technology ALliance Korea

[SIDE EVENT SESSION 2] 
ADB & Korea SIDE SESSION : Path and Innovation Towards Climate Resilience and Low-Carbon Bio Sector
Tuesday, November 21, 13:00 – 15:00   I  Grand Ballroom, 3F


Climate change has been identified as the single biggest health threat facing humanity by the World Health Organization. The health sector urgently needs to reduce its contribution to climate change, which is more than 5% of net global emissions. Climate change impacts human and animal health through extreme weather such as heatwaves, floods, and drought, through the expanding spread of infectious diseases and an added burden of non-communicable diseases, as well as through fundamental changes to the air and water supplies, and food systems. 


Addressing the environmental determinants of health should be an essential component of a One Health approach that sees human health as deeply interlinked with the health of animals, plants, the environment, and natural ecosystems. People’s physical, mental, and social health can benefit from addressing these environmental determinants of health, including those affected by climate change.


Consequently, reducing climate emissions in all sectors is needed to protect human health, animal health, and the environment from the climate crisis. It will simultaneously bring significant health gains (co-benefits) from reduced air pollution, healthy and more sustainable diets, sustainable and active transport, and more. 


Across the world, health systems in urban and rural settings face escalating challenges in responding to the myriad, growing health impacts of climate change. We must prepare for and build resilience to the impacts of extreme weather on health infrastructure, health systems themselves, and the communities they serve.


Time
Program
Speaker
13:00~13:05
Opening Remarks

Sungsup Ra

Deputy Director General and Deputy Group Chief, 

Sectors Group, Asian Development Bank(ADB)

13:05~13:15
Climate Mitigation in The Bio Health Area: 
Decarbonizing Vaccine, Pharmaceutical,
and Diagnostics Manufacturing Supply Chain

Patrick Osewe

Director-Health, Human and Social Development Sector Office, Asian Development Bank(ADB)

13:15~13:25
Animal Health and Carbon Emissions

Sanjeev Kumar Balyan

Minister, Animal Husbandry and Dairying, Government of India

13:25~13:35
Investment Framework for Climate and Health Action

Tamer Rabie

Lead Health Specialist in the World Bank's Health, 

Nutrition and Population Global Practice

13:35~13:45
Climate Change Adaptation Strategies 
for Climate Resilient Health system 
in Asia and Pacific Region

Jemilah binti Mahmood

Sunway Centre for Planetary Health, 

Sunway University Malaysia

13:45~13:55
Sustainable and Decarbonized Vaccine, Pharmaceutical, and Diagnostic Manufacturing - What are the Potential Options for Regulation?

John Skerritt

Enterprise Professor in Health Research Impact, 

University of Melbourne

13:55~14:15
Decarbonizing Vaccine, Pharmaceutical, 
and Diagnostics Manufacturing supply Chain

Sudeep Kumar

Senior Vice President, Biological E, India


Syed S Ahmed

CEO, Techno Invention

14:15∼14:55
One Health and Climate Resilient, 
Building Sustainable Low Carbon Health Care

[Moderator]

Brian Riley

Health Specialist, Human and Social Development Sector Office, Asian Development Bank(ADB)


[Panels]

Abhijit Mitra

Animal Husbandry Commissioner, Government of India


Ehsanul Kabir

Managing Director & Chief Executive Officer,

Essential Drugs Company Limited (EDCL)


Meelan Thondoo

Technical Officer on Climate Change and Health, 

World Health Organization(WHO), 

Asia-Pacific Centre for Environment 

and Health in the Western Pacific Region


[Repporter]

Jae Kyoun Kim

Health Specialist, Human and Social Development Sector Office, Asian Development Bank(ADB)

14:55∼15:00
Closing Remarks

Patrick Osewe

Director-Health, Human and Social Development Sector Office, Asian Development Bank(ADB)


SIDE EVENTS Program on November 20-21

Global Business Lounge
Monday, November 20, 12:00 – 18:00   I  Studio 8~10

Tuesday, November 21, 09:00 – 18:00  


Overview 

Create a business lounge for networking among Summit attendees, including governments and international organizations, and domestic and international pharma and biotech companies.


Attendees 

Global: Representatives from international organizations, institutions, and companies such as ADB, FIND, CEPI, etc. 

Domestic : Representatives from domestic vaccine and pharma-bio companies, etc.

Business Partnering
Monday, November 20, 15:30 – 18:00   I  Studio 4 Front Booth

Tuesday, November 21, 09:00 – 16:50 


Overview 

Operate business partnerships through preliminary demand surveys between major figures such as foreign governments, international organizations, and global pharmaceutical companies and domestic companies. 

* Reflecting demand from international organizations and foundations such as Global Seed, FIND, and Litfund for interviews with domestic companies 


Attendance 

Global: Representatives from international organizations, institutions, and companies such as ADB, FIND, CEPI, etc. 

Domestic companies: Representatives of domestic vaccine and pharmaceutical bio companies, etc.

KHIDI-FIND-RIGHT Foundation Business Networking Luncheon for Korean IVD companies 
Tuesday, November 21, 11:10 – 12:40   I  Studio 8~10


Overview 

Providing global information and networking to domestic diagnostic device companies by holding a briefing session on the RIGHT Foundation and FIND R&D projects that are in high demand by companies.


Time
Program
Speaker
11:10 ~ 11:12
Opening Remarks
Korea Health Industry Development Institute (KHIDI)
11:12 ~ 11:15
About the RIGHT Foundation 
and Assignment Call Description

RIGHT Foundation

About FIND and Its Main Business
(Biobank, etc.)

FIND

12:00 ~
Networking




WORLD BIO SUMMIT 2023 Secretariat

E-mail: worldbiosummit@korea.kr

@Copyright WORLD BIO SUMMIT 2023. All Right Reserved.